Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma
Open Access
- 27 May 2012
- journal article
- research article
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 7 (4) , 363-372
Abstract
The purpose of this study was to synthesize, characterize and tailor the surface properties of magnetic nanoparticles with biocompatible copolymer coatings and to evaluate the efficiency of the resulting nanoconjugates as magnetic resonance imaging (MRI) contrast agents for liver imaging. Magnetic nanoparticles with core diameters of 10 and 30 nm were synthesized by pyrolysis and were subsequently coated with a copolymer containing either carboxyl (SHP) or methoxy groups as termini. All four formulas, and ferumoxides (Feridex I.V.®), were individually injected intravenously into separate, normal Balb/C mice (at 2.5, 1.0 and 0.56 mg Fe kg−1), and the animals underwent T2‐weighted MRI at multiple time points post injection (p.i.) to evaluate the hepatic uptake and clearance. Furthermore, we compared the abilities of the new formulas and Feridex to detect tumors in an orthotropic Huh7 tumor model. Transmission electron microscopy (TEM) revealed a narrow size distribution of both the 10 and 30 nm nanoparticles, in contrast to a wide size distribution of Feridex. MTT, apoptosis and cyclin/DNA flow cytometry assays showed that the polymer coated nanoparticles had no adverse effect on cell growth. Among all the tested formulas, including Feridex, SHP‐30 showed the highest macrophage uptake at the in vitro level. In vivo MRI studies on normal mice confirmed the superiority of SHP‐30 in inducing hypointensities in the liver tissue, especially at clinical dose (0.56 mg Fe kg−1) and 3 T field. SHP‐30 showed better contrast‐to‐noise ratio than Feridex on the orthotropic Huh7 tumor model. SHP‐30 was found to be an efficient contrast agent for liver MR imaging. The success of this study suggests that, by improving the synthetic approach and by tuning the surface properties of IONPs, one can arrive at better formulas than Feridex for clinical practice. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 23 references indexed in Scilit:
- Targeted Nanoprobes Reveal Early Time Point Kinetics In Vivo by Time-Resolved MRITheranostics, 2011
- Investigation of In Vivo Targeting Kinetics of αvβ3-Specific Superparamagnetic Nanoprobes by Time-Resolved MRITheranostics, 2011
- Integrin Targeted MR ImagingTheranostics, 2011
- PEG-Functionalized Magnetic Nanoparticles for Drug Delivery and Magnetic Resonance Imaging ApplicationsPharmaceutical Research, 2010
- Nanoparticle-based theranostic agentsAdvanced Drug Delivery Reviews, 2010
- Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancerBiomaterials, 2010
- Highly biocompatible and water-dispersible, amine functionalized magnetite nanoparticles, prepared by a low temperature, air-assisted polyol process: a new platform for bio-separation and diagnosticsNanotechnology, 2010
- Iron Oxide Nanoparticle Platform for Biomedical ApplicationsCurrent Medicinal Chemistry, 2009
- Colorectal Hepatic Metastases: Detection with SPIO-enhanced Breath-hold MR Imaging—Comparison of Optimized SequencesRadiology, 2003
- MRI with superparamagnetic iron oxide: efficacy in the detection and characterization of focal hepatic lesionsMagnetic Resonance Imaging, 1999